Conjunctival vascular disorder

disease
On this page

Also known as conjunctival vasculature diseaseconjunctival vasculature disease or disorderdisease of conjunctival vasculaturedisease or disorder of conjunctival vasculaturedisorder of conjunctival vasculaturevascular abnormalities of conjunctiva

Summary

Conjunctival vascular disorder (MONDO:0001174) is a disease. A subtype of ocular vascular disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameconjunctival vascular disorder
Mondo IDMONDO:0001174
DOIDDOID:10989
ICD-10-CMH11.41
NCITC35116
SNOMED CT74100001
UMLSC0042370
MedGen12052
Anatomy (UBERON)UBERON:0010366
Is cancer (heuristic)no

Also known as: conjunctival vascular disorder · conjunctival vasculature disease · conjunctival vasculature disease or disorder · disease of conjunctival vasculature · disease or disorder of conjunctival vasculature · disorder of conjunctival vasculature · vascular abnormalities of conjunctiva

Disease family

Classification path: disease › human disease › disease by body system or component › disorder of orbital regioneye disorder › ocular vascular disorder › conjunctival vascular disorder

Related subtypes (2): optic choroid disorder, retinal vascular disorder

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.